Negative effects of drug data protection system on drug availability — an empirical analysis of America lamotrigine case
10.11665/j.issn.1000-5048.20150418
- VernacularTitle:药品数据保护制度对药品可及性负效应研究——基于美国拉莫三嗪案例的实证分析
- Author:
Jinxi DING
1
;
Yangyang LIU
;
Jianzhou YAN
Author Information
1. 中国药科大学国际医药商学院
- Publication Type:Journal Article
- Keywords:
drug data protection;
availability;
lamotrigine;
empirical analysis
- From:
Journal of China Pharmaceutical University
2015;46(4):493-498
- CountryChina
- Language:Chinese
-
Abstract:
This paper explores the relevance between data protection system and drug availability through the American lamotrigine(lamictal® )case. Results indicated that drug data protection system delays the marketing of genetics, hinders the pricing regulation of innovative drugs timely and effectively, and affects drug availability severely. With reference to America, it is urgent to design the scope of data protection system reasonably, and set the first generic drug regime and other supporting measures so as to reduce the negative effects of drug data protection system and improve the health benefits of the public.
